644 related articles for article (PubMed ID: 30742067)
1. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M
Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067
[TBL] [Abstract][Full Text] [Related]
2. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer.
Wu H; Liu B; Chen Z; Li G; Zhang Z
Cell Death Dis; 2020 Apr; 11(4):233. PubMed ID: 32300102
[TBL] [Abstract][Full Text] [Related]
3. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.
Chen Z; Xu P; Wang X; Li Y; Yang J; Xia Y; Wang S; Liu H; Xu Z; Li Z
Cancer Lett; 2023 Jul; 565():216235. PubMed ID: 37209945
[TBL] [Abstract][Full Text] [Related]
4. MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
Han J; Qu H; Han M; Ding Y; Xie M; Hu J; Chen Y; Dong H
Oncogene; 2021 Jan; 40(4):833-847. PubMed ID: 33273726
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1.
Zhao Y; Liu Y; Lin L; Huang Q; He W; Zhang S; Dong S; Wen Z; Rao J; Liao W; Shi M
Mol Cancer; 2018 Mar; 17(1):69. PubMed ID: 29510730
[TBL] [Abstract][Full Text] [Related]
6. CMYC-initiated HNF1A-AS1 overexpression maintains the stemness of gastric cancer cells.
Zhao R; Guo X; Zhang G; Liu S; Ma R; Wang M; Chen S; Zhu W; Liu Y; Gao P; Liu H
Cell Death Dis; 2024 Apr; 15(4):288. PubMed ID: 38654006
[TBL] [Abstract][Full Text] [Related]
7. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.
Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H
Cell Metab; 2018 Jan; 27(1):136-150.e5. PubMed ID: 29249690
[TBL] [Abstract][Full Text] [Related]
8. MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.
Duan J; Chen L; Zhou M; Zhang J; Sun L; Huang N; Bin J; Liao Y; Liao W
Oncol Rep; 2017 May; 37(5):2583-2592. PubMed ID: 28339092
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
[No Abstract] [Full Text] [Related]
10. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2.
Qu F; Cao P
Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling.
Zhang RM; Tang T; Yu HM; Yao XD
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):260-266. PubMed ID: 30442366
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability.
Xu Q; Lin YB; Li L; Liu J
Biochem Biophys Res Commun; 2020 Jun; 526(4):857-864. PubMed ID: 32278547
[TBL] [Abstract][Full Text] [Related]
13. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HAND2-AS1 inhibits non-small cell lung cancer migration, invasion and maintains cell stemness through the interactions with TGF-β1.
Miao F; Chen J; Shi M; Song Y; Chen Z; Pang L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509963
[TBL] [Abstract][Full Text] [Related]
15. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
[TBL] [Abstract][Full Text] [Related]
17. Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer.
Zhu L; Zhu Y; Han S; Chen M; Song P; Dai D; Xu W; Jiang T; Feng L; Shin VY; Wang X; Jin H
Cell Death Dis; 2019 May; 10(6):383. PubMed ID: 31097692
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2.
Wang X; Yu X; Wei W; Liu Y
Environ Toxicol; 2020 Sep; 35(9):998-1006. PubMed ID: 32401390
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation.
Li R; Chen S; Zhan J; Li X; Liu W; Sheng X; Lu Z; Zhong R; Chen L; Luo X; Hu Y; Ouyang Y; Liu T; Zhang Q; Zhang S
Cell Death Dis; 2020 Jan; 11(1):41. PubMed ID: 31959918
[TBL] [Abstract][Full Text] [Related]
20. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer.
Wu S; Xie J; Shi H; Wang ZW
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32065219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
